Trial Design Articles

Applied Clinical Trials: Feb 01, 2015
New study highlights the importance of focusing on non-core procedures to better optimize study design.
Applied Clinical Trials: Feb 01, 2015
Cancer Research UK applies risk-based monitoring across its entire trial portfolio. What were the results?
Applied Clinical Trials: Feb 01, 2015
Examining the design, implementation, and challenges of this direct-to-patient study model.
Applied Clinical Trials: Jan 22, 2015
Over recent years global drug companies large or small have recognized that one root cause of the high failure rate in their clinical development lies in the selection of right therapeutic targets.
Applied Clinical Trials: Jan 19, 2015
Case Study, Trigemina TI-001 for high frequency migraine
Applied Clinical Trials: Dec 01, 2014
Based on nearly 850 responses, a recent CISCRP study finds that the European public considers clinical research to be riskier than does the public in many other global regions.
Applied Clinical Trials: Sep 30, 2014
A systematic approach for early identification of BP effects during development of new drugs.
Applied Clinical Trials: Sep 30, 2014
Proving a biosimilar's pharmacokinetic 'equivalence' requires adherence to several unique factors.
Applied Clinical Trials: Sep 30, 2014
How modeling and simulation clarified complex exposure levels and an orphan drug got approved.
Applied Clinical Trials: Sep 30, 2014
Research shows that the potential of integrated alliances remains elusive in the near term.

Trial Design News

PHT Offers Rater Training in Three Instruments

The pharmaceutical industry is further optimizing the collection of high quality electronic patient reported outcomes (ePROs) data for clinical research, with PHT Corporation Rater Training programs

Covance Solution Bridges Preclinical to Clinical Development

Covance Inc., the world’s most comprehensive drug development company, today announced the introduction of Covance Early Phase Development Solutions,

Novella Clinical Partners with Academia on CV Clinical Trials Services

Novella Clinical and the Cardiovascular Research Foundation announced a preferred provider collaboration.

Almac Releases ePRO Data

Almac announced the results of a survey conducted by researchers at the Tufts Center for the Study of Drug Development.

Mapi Group Acquires Select Services of Optum Life Sciences

Mapi has completed the acquisition of select Optum Life Sciences services.